This site is intended for health professionals only
Monday 22 October 2018
Share |

Topic: Latest News

October 17, 2018
Pharmacists must implement new validation processes from today (17 October) to prioritise the limited stocks of EpiPen junior 150 microgram (mcg), the Department of Health and Social Care (DHSC) and NHS England have said.

Pharmacists must implement new validation processes from today (17 October) to prioritise the limited stocks of EpiPen junior 150 microgram (mcg), the Department of Health and Social Care (DHSC) and NHS England have said.

October 17, 2018
Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the Government has said.

Pregabalin and gabapentin will be reclassified as class C drugs next year following a rising numbers of deaths linked to the drugs, the UK Government has said.
 

October 16, 2018
MPs have called on the Government to guarantee the continuity of medicine supplies after Brexit.

MPs have called on the Government to guarantee the continuity of medicine supplies after Brexit.
 
A report published by parliamentary select committee the Public Accounts Committee (PAC) on Friday (12 October) urged the Department of Health and Social Care (DHSC) to share its action plan by December to ensure medicine supplies and address price increasesbefore and after the UK leaves the EU.
 

October 12, 2018
The UK's pharmacy regulator the General Pharmaceutical Council (GPhC) will consult on raising its registration its registration fees for 2019/20 – the first time it has proposed increasing them since 2015 – it has announced.

The UK's pharmacy regulator the General Pharmaceutical Council (GPhC) will consult on raising its registration its registration fees for 2019/20 – the first time it has proposed increasing them since 2015 – it has announced.
The regulator is proposing that pharmacists' fees should raise by £7 to £257, pharmacy technicians' fees should raise by £3 to £121 and pharmacy premises fees should raise by £21 to £262.
The proposed fees are still lower than 2011's fees, the GPhC highlighted.

October 9, 2018
A no-deal Brexit would put a stop to the the falsified medicines directive (FMD) in the UK, the Department of Health and Social Care (DHSC) has said.

A no-deal Brexit would put a stop to the the falsified medicines directive (FMD) in the UK, the Department of Health and Social Care (DHSC) has said.
 

October 2, 2018
Antidepressants have more severe withdrawal symptoms than guidelines suggest, says research

Millions of antidepressant users could experience "severe withdrawals” if they cut down or come off their medication, according to a new review.
 
The UK’s All Party Parliamentary Group (APPG) for Prescribed Drug Dependence reviewed the withdrawal affects of antidepressants across 23 existing studies and found that withdrawals are much more widespread, severe and long lasting than current guidelines suggest.
 

October 2, 2018
Patients told to use EpiPens up to four months past expiry date amid shortages

Patients with severe allergies can use certain batches of EpiPen four months after their expiry date, the Government has said.
 
In a supply alert issued last week (28 September), the Department of Health and Social Care (DHSC) said that patients can use some batches of EpiPen and EpiPen Junior, due to "limited availability for the remainder of 2018".
 
"Limited availability"
 

September 28, 2018
Hannah Beba is a senior pharmacist practising in the diabetes and endocrinology fields at the County Durham and Darlington NHS Foundation Trust. She is also one of the charity Diabetes UK clinical champions and an independent prescriber. She talks to Léa Legraien about her successes, challenges and love for the profession.

Hannah Beba is a senior pharmacist practising in the diabetes and endocrinology fields at the County Durham and Darlington NHS Foundation Trust. She is also one of the charity Diabetes UK clinical champions and an independent prescriber.
 
She talks to Léa Legraien about her successes, challenges and love for the profession.
 
 
Q Why did you become a pharmacist?
 
 

September 27, 2018
An award winning hospital team dedicated to tackling antimicrobial resistance talk about their efforts to tackle this issue and why staff engagement is essential to running a successful programme

An award winning hospital team dedicated to tackling antimicrobial resistance talk about their efforts to tackle this issue and why staff engagement is essential to running a successful programme
 
Hala Kandil, microbiology consultant and antimicrobial resistance (AMR) lead, and Tejal Vaghela, lead antimicrobial pharmacist work together at Hertfordshire Hospitals NHS Trust in the UK to help tackle antimicrobial resistance.
 

September 21, 2018
European Commission approves BRAFTOVI and MEKTOVI to treat advanced BRAF-mutant melanoma

The European Commission (EC) had approved the use of BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) to treat adults with advanced BRAF-mutant melanoma.
 
The EC’s decision is based on results from the Phase 3 COLUMBUS trial, which demonstrated 14.9 months median progression-free survival and 33.6 months median overall survival with the combination therapyversus vemurafenib monotherapy with 7.3 and 16.9 months, respectively.
 

September 7, 2018
‘Hard look’ at gender parity needed as pharmacy’s female workforce set to grow

A ‘hard look’ at gender parity issues will be vital as the proportion of women working in pharmacy increases, a representative body for the sector has warned.
 

September 7, 2018
Pharmacists’ potential to empower female carers ‘overlooked’, report says

Pharmacists could do more to empower female carers, a representative body for the sector has urged.
 

September 7, 2018
Six in 10 pharmacy professionals in favour of banning homeopathy prescribing

Six in 10 pharmacy professionals are against the sale and dispensing of homeopathic products, pharmacists at an international conference have heard.

August 30, 2018
The European Commission has approved Vyxeos 44 mg/100mg powder for concentrate for solution for infusion for the treatment of adults with newly-diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes, manufacturer Jazz Pharmaceuticals has announced.

The European Commission has approved Vyxeos 44 mg/100mg powder for concentrate for solution for infusion for the treatment of adults with newly-diagnosed, therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes, manufacturer Jazz Pharmaceuticals has announced.
 
Vyxeos is an advanced liposomal formulation that delivers a synergistic molar ration of daunorubicin and cytarabine, Jazz Pharmaceuticals said.
 
The EC approval extends to all European member states as well as Iceland, Norway sand Liechtenstein.

August 30, 2018
Novartis UK Oncology statement on Novartis receiving European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)

Novartis UK Oncology statement on Novartis receiving European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)
 
"Today’s (27 August) approval by the European Commission of Kymriah® (tisagenlecleucel), the only CAR-T therapy licensed in two different types of blood cancers, moves us one step closer to providing this revolutionary therapy to appropriate patients in the UK. 
 
 
 

August 23, 2018
Kathy Oxtoby looks at the effects of antimicrobial resistance across Europe will be if it goes unchecked and investigates what should be done to tackle it

Kathy Oxtoby looks at the effects of antimicrobial resistance across Europe will be if it goes unchecked and investigates what should be done to tackle it
 
It may be a natural phenomenon, but antimicrobial resistance (AMR) has become a global health crisis of similar importance to infectious-disease pandemics, according to the World Health Organization (WHO).
 

August 23, 2018
Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska

Working as a pharmacist in the Central African Republic and the Democratic Republic of the Congo was a rewarding experience, despite considerable challenges, explains Barbara Pawulska
 
What with busy dispensaries and tricky patients to contend with, life as a pharmacist can present challenges in any walk of the profession.
 

August 14, 2018
Only one third of pharmaceutical companies are compliant with Europan anti-counterfeiting measures, according to a representative group.

Only one third of pharmaceutical companies are compliant with Europan anti-counterfeiting measures, according to a representative group.
 
In a letter sent last week (6 August), the European Medicines Verification Organisation (EMVO) said that of the 2,291 pharmaceutical companies that have to connect to the European Medicines Verification System (EMVS) in less than six months, only 841 (36%) have signed the required agreement. 
 

August 14, 2018
The prescribing safety assessment (PSA) could benefit pre-registration pharmacy students who want to become independent prescribers, a study has concluded.

The prescribing safety assessment (PSA) could benefit UK pre-registration pharmacy students who want to become independent prescribers, a study has concluded.
 
The PSA is a 60-minute evaluation of 30 questions on writing and reviewing new prescriptions, calculating drug doses and identifying and avoiding adverse drug reactions and medication errors, among others.
 

August 8, 2018
Senior clinicians will be able to legally prescribe cannabis-derived medicines this autumn, the Home Office has announced.

Senior clinicians will be able to legally prescribe cannabis-derived medicines this autumn, the UK's Home Office has announced.
 

August 8, 2018
New restricted indications on prescribing Esmya (ulipristal acetate) for symptoms of uterine fibroids have been put in place by the UK’s medicines watchdog

New restricted indications on prescribing Esmya (ulipristal acetate) for symptoms of uterine fibroids put in place by the UK’s medicines watchdog now replace instructions that the drug should not be prescribed to any new patients.
 

August 6, 2018
New patient groups with cancer-associated venous thromboembolism (VTE) could benefit from taking once-daily oral LIXIANA (edoxaban), a recent analysis has said.

New patient groups with cancer-associated venous thromboembolism (VTE) could benefit from taking once-daily oral LIXIANA (edoxaban), a recent analysis has said.
 
Manufacturer Daiichi Sankyo announced today (6 July) it had published a new analysis on the clinical presentation, course and outcome of bleeding events in Thrombosis and Haemostasis, and the associated tumour types from the Hokusai-VTE cancer study.
 

August 2, 2018
The Government should consider the economic as well as health benefits of vaccinating people against flu, according to research by a think tank

The Government should consider the economic as well as health benefits of vaccinating people against flu, according to research by a think tank.
 
Research by the International Longevity Centre – UK (ILC-UK) argued that flu can adversely affect productivity within the economy. The biggest economic benefit of vaccinating against the condition is the reduction of lost employment and care giving costs, which total between £90m and £270m , it said.
 

August 1, 2018
More than 3000 participants from 75 countries gathered in Gothenburg for the 23rd congress of EAHP. The meeting covered a range of hospital pharmacy activities and highlights included biosimilars in oncology, advanced therapy medicinal products and post-operative analgesia
Anna de Goede
Anna de Goede
 
Richard Langford
Richard Langford
 
Eric Viel
Eric Viel

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine